Vaccinia Immune Globulin Intravenous
GPTKB entity
Statements (30)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
immunoglobulin therapy
biological drug |
| gptkbp:administeredBy |
intravenous route
|
| gptkbp:alternativeTo |
gptkb:Vaccinia_Immune_Globulin_(intramuscular)
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
gptkb:J06BB08
|
| gptkbp:contains |
antibodies to vaccinia virus
|
| gptkbp:contraindication |
IgA deficiency with antibodies against IgA
|
| gptkbp:developedBy |
gptkb:US_Centers_for_Disease_Control_and_Prevention
|
| https://www.w3.org/2000/01/rdf-schema#label |
Vaccinia Immune Globulin Intravenous
|
| gptkbp:indication |
patients with complications from smallpox vaccination
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:marketedAs |
gptkb:VIGIV
|
| gptkbp:notRecommendedFor |
prevention of smallpox
treatment of smallpox infection uncomplicated vaccinia |
| gptkbp:producedBy |
plasma of individuals vaccinated with vaccinia virus
|
| gptkbp:sideEffect |
fever
nausea headache chills allergic reactions |
| gptkbp:storage |
refrigerated
|
| gptkbp:usedFor |
treatment of eczema vaccinatum
treatment of progressive vaccinia treatment of severe generalized vaccinia treatment of complications from vaccinia vaccination treatment of accidental implantation of vaccinia virus |
| gptkbp:bfsParent |
gptkb:Vaccinia_Immune_Globulin
|
| gptkbp:bfsLayer |
7
|